The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Patients With Primary Biliary Cirrhosis React Against A Ubiquitous Xenobiotic–Metabolizing Bacterium
Open accessAbstract
Infectious and environmental agents have been proposed as immunologic triggers for primary biliary cirrhosis (PBC). Recently, a ubiquitous organism that metabolizes organic compounds and estrogens, Novosphingobium aromaticivorans, has been defined. Importantly, 2 bacterial proteins have homology with the E2 component of the pyruvate dehydrogenase complex (PDC–E2). Sera from 97 patients with PBC, 46 first–degree relatives, 10 spouses, and 195 controls were studied for reactivity against N. aromaticivorans and Escherichia coli. The reactivity was defined by absorption, affinity purification, and using monoclonal antibodies to PDC–E2. Stool samples from 20 patients with PBC and 34 controls were analyzed by polymerase chain reaction (PCR) for the presence of N. aromaticivorans. Sera from 100% of anti–PDC–E2 positive (77/77), 33% of anti–BCOADC E2 positive (1/3), and 12% of antimitochondrial antibody (AMA) negative patients with PBC (2/17) reacted with titers up to 10-6 against two known lipoylated bacterial proteins (47 and 50 kd) from N. aromaticivorans, including patients with early disease. This titer was approximately 100– to 1,000–fold higher than against E. coli and verified by absorption, use of affinity–purified sera, and monoclonal antibody reagents. Moreover, 78 of 80 AMA–positive and 5 of 17 AMA–negative patients with PBC had antibodies against 3 other N. aromaticivorans proteins. In contrast, 0 of 195 control sera reacted against N. aromaticivorans. Approximately 25% of patients and controls had N. aromaticivorans in their fecal specimens. In conclusion, based on protein homology, capacity to metabolize xenobiotics as well as modulate estrogens, its presence in feces, and specific immunologic response, we propose that N. aromaticivorans is a candidate for the induction of PBC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The existence of disease clustering points to environmental triggers, and research has supported both infectious and chemical triggers.22 28 57–61”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [61]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 2,016
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Takeuchi, M., Hamana, K., & Hiraishi, A. (2001) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/00207713-51-4-1405 · Cited by 792
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Kaplan, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352107 · Cited by 459
Primary biliary cirrhosis: an orchestrated immune response against epithelial cells
Gershwin, M. E., Ansari, A. A., Mackay, I. R., Nakanuma, Y., Nishio, A., Rowley, M. J., & Coppel, R. L. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017402.x · Cited by 275
Self-citationAromatic-degrading Sphingomonas isolates from the deep subsurface
Fredrickson, J. K., Balkwill, D. L., Drake, G. R., Romine, M. F., Ringelberg, D. B., & White, D. C. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.5.1917-1922.1995 · Cited by 245
Self-citationSantantonio, T., Mazzola, M., Iacovazzi, T., Miglietta, A. S., Guastadisegni, A., & Pastore, G. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80076-8 · Cited by 240
Does a betaretrovirus infection trigger primary biliary cirrhosis?
Xu, L., Shen, Z., Guo, L., Fodera, B., Keogh, A., Joplin, R., O’Donnell, B., Aitken, J. D., Carman, W. F., Neuberger, J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433063100 · Cited by 223
Odin, J. A., Huebert, R. C., Casciola-Rosen, L., LaRusso, N. F., & Rosen, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200110716 · Cited by 220
Miyakawa, H., Tanaka, A., Kikuchi, K., Matsushita, M., Kitazawa, E., Kawaguchi, N., Fujikawa, H., & Gershwin, E. M. (2001) · Hepatology · doi:10.1053/jhep.2001.26514 · Cited by 200
Self-citationMolecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences
Bogdanos, D. P., Choudhuri, K., & Vergani, D. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021004225.x · Cited by 175
Long, S. A., Quan, C., de Water, J. V., Nantz, M. H., Kurth, M. J., Barsky, D., Colvin, M. E., Lam, K. S., Coppel, R. L., Ansari, A. A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2956 · Cited by 161
Self-citationFujii, K., Kikuchi, S., Satomi, M., Ushio-Sata, N., & Morita, N. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.4.2057-2060.2002 · Cited by 160
Fussey, S. P. M., Ali, S. T., Guest, J. R., James, O., Bassendine, M. F., & Yeaman, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3987 · Cited by 143
Perola, O., Nousiainen, T., Suomalainen, S., Aukee, S., Kärkkäinen, U., Kauppinen, J., Ojanen, T., & Katila, M. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1163 · Cited by 105
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases
Muratori, P., Muratori, L., Guidi, M., Maccariello, S., Παππάς, Γ., Ferrari, R., Gionchetti, P., Campieri, M., & Bianchi, F. B. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02166.x · Cited by 102
The Geoepidemiology of Primary Biliary Cirrhosis
Metcalf, J. V., & James, O. (1997) · Seminars in Liver Disease · doi:10.1055/s-2007-1007179 · Cited by 100
Hiramatsu, K., Harada, K., Tsuneyama, K., Sasaki, M., Fujita, S., Hashimoto, T., Kaneko, S., Kobayashi, K., & Nakanuma, Y. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80153-1 · Cited by 97
Molecular Mimicry and Primary Biliary Cirrhosis: Premises Not Promises
de Water, J. V., Ishibashi, H., Coppel, R. L., & Gershwin, E. M. (2001) · Hepatology · doi:10.1053/jhep.2001.23902 · Cited by 91
Self-citationSHI, T., Fredrickson, J. K., & Balkwill, D. L. (2001) · Journal of Industrial Microbiology & Biotechnology · doi:10.1038/sj.jim.7000130 · Cited by 87
Self-citationAre infectious agents involved in primary biliary cirrhosis? A PCR approach
Tanaka, A., Prindiville, T. P., Gish, R. G., Solnick, J. V., Coppel, R. L., Keeffe, E. B., Ansari, A. A., & Gershwin, M. E. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80346-8 · Cited by 83
Self-citationMigliaccio, C. T., Nishio, A., de Water, J. V., Ansari, A. A., Leung, P. S. C., Nakanuma, Y., Coppel, R. L., & Gershwin, M. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5157 · Cited by 83
Self-citationHakala, M., Pöllänen, R., & Nieminen, P. A. (1993) · PubMed · Cited by 71
Management of Primary Sclerosing Cholangitis
Lee, Y., & Kaplan, M. M. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05585.x · Cited by 66
Parikh‐Patel, A., Gold, E. B., Mackay, I. R., & Gershwin, M. E. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4690 · Cited by 59
Fussey, S. P. M., Lindsay, G. J., Fuller, C., Perham, R. N., Dale, S. J., James, O., Bassendine, M. F., & Yeaman, S. J. (1991) · Hepatology · doi:10.1002/hep.1840130314 · Cited by 58
Mismatch Repair-Driven Mutational Bias in D. melanogaster
Harr, B., Todorova, J., & Schlötterer, C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00575-0 · Cited by 56
Lemaitre, D., Elaichouni, A., Hundhausen, M., Claeys, G., Vanhaesebrouck, P., Vaneechoutte, M., & Verschraegen, G. (1996) · Journal of Hospital Infection · doi:10.1016/s0195-6701(96)90146-2 · Cited by 52
Butler, P., Hamilton-Miller, J. M. T., McIntyre, N., & Burroughs, A. K. (1995) · Gut · doi:10.1136/gut.36.6.931 · Cited by 45
Mayo, I., Arizti, P., Parés, A. R., Oliva, J., Doforno, R. Á., de Sagarra, M. R., Rodés, J., & Castaño, J. G. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80003-3 · Cited by 43
Is there a Relation between Chlamydia Infection and Primary Biliary Cirrhosis?
Leung, P. S. C., Park, O., Matsumura, S., Ansari, A. A., Coppel, R. L., & Gershwin, M. E. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001642429 · Cited by 38
Self-citationPhysiological and Genetic Comparison of Two Aromatic Hydrocarbon-degrading Sphingomonas Strains
Shuttleworth, K. L., Sung, J., Kim, E., & Cerniglia, C. E. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0199-x · Cited by 26
Anti-Saccharomyces cerevisiae antibodies in autoimmune liver disease
Reddy, K. R., Colombel, J., Poulain, D., & Krawitt, E. L. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02283-8 · Cited by 26
Urinary tract infections in primary biliary cirrhosis and other chronic liver diseases
O’Donohue, J., Workman, M. R., Rolando, N., Yates, M. D., Philpott‐Howard, J., & Williams, R. L. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01709256 · Cited by 24
Sasaki, M., Ansari, A. A., Pumford, N. R., de Water, J. V., Leung, P. S. C., Humphries, K. M., Szweda, L. I., Nakanuma, Y., Roche, T. E., Coppel, R. L., et al. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0390 · Cited by 19
Self-citationBogdanos, D. P., Grasso, A., Okamoto, M., Montalto, P., Butler, P., Williams, R., Baum, H., Burroughs, A. K., & Vergani, D. (2000) · UCL Discovery (University College London) · Cited by 8
Detection of retroviral antibodies in primary biliary cirrhosis
Weber, B., Berger, A., & Doerr, H. W. (1998) · The Lancet · doi:10.1016/s0140-6736(98)85060-5 · Cited by 6
Flagged first, then by citations
Research works printed but not linked: 4
- Shuttleworth, 2000, Mol Cell, 10, 199
- Hakala, 1993, J Rheumatol, 20, 1674
- Leung, 2002, Hepatology, 36, 388a
- Reddy, 2001, Am J Gastroenterol, 96, 252, 10.1111/j.1572-0241.2001.03490.x · DOI
Cited by
Sorted by citations
Bendelac, A. S., Savage, P. B., & Teyton, L. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141711 · Cited by 2,169
Kaplan, M. M., & Gershwin, M. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043898 · Cited by 1,144
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
Mattner, J., DeBord, K. L., Ismail, N., Goff, R. D., Cantu, C., Zhou, D., Saint-Mézard, P., Wang, V., Gao, Y., Yin, N., et al. (2005) · Nature · doi:10.1038/nature03408 · Cited by 1,121
The cholangiopathies: Disorders of biliary epithelia
Lazaridis, K. N., Strazzabosco, M., & LaRusso, N. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.006 · Cited by 369
Hirschfield, G. M., Dyson, J. K., Alexander, G. J. M., Chapman, M. H., Collier, J., Hübscher, S., Patanwala, I., Pereira, S. P., Thain, C., Thorburn, D., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315259 · Cited by 362
Metadata
- Authors
- Selmi, C., Balkwill, D. L., Invernizzi, P., Ansari, A. A., Coppel, R. L., Podda, M., Leung, P. S., Kenny, T. P., Van De Water, J., Nantz, M. H., Kurth, M. J., & Gershwin, E. M.
- Affiliations
- University of Milan (IT)
- Florida State University (US)
- Emory University (US)
- Monash University (AU)
- University of California, Davis (US)
- Corresponding author
- Gershwin, Eric M.
- ORCID
- Venue
- Hepatology
- Published
- 2003-11
- Volume
- 38
- Issue
- 5
- Pages
- 1250-1257
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2151434633
- Cited by
- 312
- References
- 38
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 6 · 2023: 11 · 2022: 10 · 2021: 11 · 2020: 8 · 2019: 7 · 2018: 14 · 2017: 4 · 2016: 4 · 2015: 16 · 2014: 9 · 2013: 25 · 2012: 19
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK 39588)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 39588)
- National Institute of Environmental Health Sciences (ES103019)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- primary biliary cirrhosis, Novosphingobium aromaticivorans, autoantibodies, pyruvate dehydrogenase E2, antimitochondrial antibodies, fecal bacteria, Escherichia coli
- MeSH terms
- Amino Acid Sequence, Bacterial Infections, Bacterial Proteins, Feces, Female, Humans, Liver Cirrhosis, Biliary, Male, Molecular Sequence Data, Pyruvate Dehydrogenase Complex, Xenobiotics, Case-Control Studies, Sequence Homology, Amino Acid, Molecular Mimicry, Alphaproteobacteria, Dihydrolipoyllysine-Residue Acetyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
